The European Research Council (ERC) has awarded with a Starting Grant

for scientific excellence Oriol Casanovas, researcher at IDIBELL and at the Catalan Institute of Oncology for the project ‘Mechanisms and Targeting Stromal Tumor Invasion Contribution tone and Metastasis’.

The funded project, called Stromalign, focuses on the study of tumor stroma as a possible major factor in the malignancy after anti-angiogenic therapies. The grant is 1.5 billion over five years. The funded project, called Stromalign, focuses on the study of tumor stroma as a possible major factor in the malignancy after anti-angiogenic therapies. ERC funds the program with 1,5 milions Euros in 5 years.

More information: www.iconcologia.net